CoChat

Systematic review with meta‐analysis: effect of fibre supplementation on chronic idiopathic constipation in adults

Open access
Christodoulides, S., Dimidi, E., Fragkos, K. C., Farmer, A. D., Whelan, K., Scott, S. M. · 2016 · Alimentary Pharmacology & Therapeutics
Cited by 144

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Summary: Background: Chronic idiopathic constipation is a common symptom‐based gastrointestinal disorder responsible for a substantial economic health service burden. Current guidelines recommend the use of fibre as a first‐line treatment. Aim: To investigate the effect of fibre (including prebiotic) supplementation on global symptom response, stool output, gut microbiota composition and adverse events in adults with chronic idiopathic constipation. Methods: Medline, EmBase, Web of Science, Scopus and the Cochrane central register of controlled trials were searched through to February 2016. Conference proceedings from 2003 to 2015 were hand‐searched. There were no language restrictions. Forest plots with 95%CI s were generated using a random‐effects model. Results: The search strategy generated 1072 citations, of which seven individual randomised controlled trials were eligible. Overall, 113 of 147 (77%) patients assigned to fibre responded to therapy, compared with 61 of 140 (44%) allocated to placebo (RR of success to respond 1.71, 95%CI 1.20–2.42,P= 0.003). Fibre significantly increased stool frequency (SMD, standardised mean difference = 0.39; 95%CI 0.03–0.76;P= 0.03) and softened stool consistency (SMD= 0.35; 95%CI 0.04–0.65;P= 0.02) compared with placebo. Flatulence was significantly higher with fibre compared to placebo (SMD 0.56, 0.12–1.00,P= 0.01). Overall quality of evidence was low. Conclusions: This meta‐analysis demonstrates that fibre is moderately effective, but also causes moderate gastrointestinal side effects. However, these findings need to be treated with caution due to a high risk of bias. Accordingly, further large, methodologically rigorous trials are required, before any definitive recommendation regarding its risk–benefit profile can be made. PROSPERO registration number CRD42014007005.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.13662

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 144

Metadata

Authors
Christodoulides, S., Dimidi, E., Fragkos, K. C., Farmer, A. D., Whelan, K., & Scott, S. M.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2016-05-12
Volume
44
Issue
2
Pages
103-116
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2380493244
Cited by
144
References
21
FWCI
2.03
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.